Suscribirse

Hereditary Angioedema with Normal C1 Inhibitor: Clinical Symptoms and Course - 09/08/11

Doi : 10.1016/j.amjmed.2007.08.021 
Konrad Bork, MD a, ⁎ , Döndü Gül, MD a, Jochen Hardt, PhD b, Georg Dewald, MD a
a Department of Dermatology, Johannes Gutenberg University, Mainz, Germany 
b Clinic for Psychosomatic Medicine, Heinrich Heine University, Duesseldorf, Germany 

Requests for reprints should be addressed to Konrad Bork, MD, Department of Dermatology, Johannes Gutenberg University, Langenbeckstr. 1, 55131 Mainz, Germany.

Abstract

Purpose

A new type of hereditary angioedema was described recently. It was characterized by recurrent bouts of angioedema in various organs and normal C1 inhibitor and was observed mainly in women. Our aim was to conduct a detailed study of the clinical features of this condition.

Methods

A total of 138 patients with hereditary angioedema and normal C1 inhibitor who belonged to 43 unrelated families were examined through the use of standardized questionnaires.

Results

A majority of patients with hereditary angioedema and normal C1 inhibitor had skin swellings (92.8%), tongue swellings (53.6%), and abdominal pain attacks (50%). Laryngeal edema (25.4%) and uvular edema (21.7%) also were frequent, whereas edema episodes of other organs were rare (3.6%). Facial swellings and tongue involvement occurred considerably more frequently compared with hereditary angioedema caused by C1 inhibitor deficiency. The number of patients with recurrent edema of only 1 organ was higher than in classic hereditary angioedema. The number of patients with disease onset in adulthood was significantly higher in hereditary angioedema with normal C1 inhibitor compared with classic hereditary angioedema. Erythema marginatum was not observed. A subgroup of patients from families with coagulation factor XII mutations showed the same symptoms as the other patients.

Conclusions

Hereditary angioedema with normal C1 inhibitor levels shows a characteristic pattern of clinical symptoms. The main clinical features include skin swellings, tongue swellings, and abdominal pain attacks. There are many differences in the clinical symptoms and course of disease between this type of hereditary angioedema and classic hereditary angioedema caused by a genetic C1 inhibitor deficiency.

El texto completo de este artículo está disponible en PDF.

Keywords : Angioedema, Hereditary Angioedema, Hereditary Angioedema Type III, Coagulation Factor XII, F12 Gene Mutations, C1 Inhibitor Deficiency


Esquema


© 2007  Elsevier Inc. Reservados todos los derechos.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Vol 120 - N° 11

P. 987-992 - novembre 2007 Regresar al número
Artículo precedente Artículo precedente
  • Chronic Kidney Disease Prevalence and Rate of Diagnosis
  • Timothy P. Ryan, James A. Sloand, Paul C. Winters, James P. Corsetti, Susan G. Fisher
| Artículo siguiente Artículo siguiente
  • TIMI Risk Index and the Benefit of Enoxaparin in Patients with ST-Elevation Myocardial Infarction
  • Christian T. Ruff, Stephen D. Wiviott, David A. Morrow, Satishkumar Mohanavelu, Sabina A. Murphy, Elliott M. Antman, Eugene Braunwald, ExTRACT-TIMI 25 Investigators

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.

¿Ya suscrito a @@106933@@ revista ?

@@150455@@ Voir plus

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2026 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.